Measuring the Burden of Disease in Korea by Yoon, Seok-Jun et al.
INTRODUCTION
In this study, we provide an overview of the Korean Bur-
den of Disease (KBoD) study, which was the first study of
its type to assess the national burden of disease in an advanced
Asian country, using disability-adjusted life years (DALYs)
as measures of disability. 
Burden of disease measurements that employ DALYs have
been previously utilized by several studies conducted at inter-
national and national levels (1-5).
The DALYs concept was initially developed by Murray
and Lopez, and was applied for the first time in their author-
itative Global Burden of Disease (GBD) project (6, 7). This
project commenced in the early 1990s and involved researchers
in many countries. Moreover, its results have been published
in a variety of forms, and researchers in many countries in-
volved, and continue to make, recommendations at the nation-
al level and expedite programs that properly address the bur-
den of disease issues raised by the GBD (3, 8). In Korea, chang-
ing disease trends have been observed over recent years. Spe-
cifically, the natures and magnitudes of the threats posed by
contagious diseases have receded, whereas the prevalences of
non-contagious and chronic diseases have increased (9). More-
over, such changes weigh heavily on the national healthcare
system, and make the process of resource allocation a difficult
proposition (10). 
In this article, we describe some of the key findings of the
KBoD study, which was initiated in the early 2000s and con-
tinues today. 
MATERIALS AND METHODS
Overview
In general, the KBoD study followed the protocols of the
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Measuring the Burden of Disease in Korea
This paper provides an overview of the Korean Burden of Disease (KBoD) study,
which was the first such study to assess the national burden of disease using dis-
ability-adjusted life years (DALYs) in an advanced Asian country. The KBoD study
generally followed the approach utilized in the original Global Burden of Disease
study (GBD), with the exception of the disease classification and epidemiological
data estimation methods used, and the relative weightings of disabilities. The results
of the present study reveal that the burden of disease per 100,000 of the Korean
population originates primarily from; cancer (1,525 Person Years, PYs), cardiovas-
cular disease (1,492 PYs), digestive disease (1,140 PYs), diabetes mellitus (990
PYs), and certain neuro-psychiatric conditions (883 PYs). These results are largely
consistent with those of developed countries, but also represent uniquely Korean
characteristics.
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original GBD study (6). However, the KBoD study differs
in terms of the detailed methodology used with respect to;
the disease classification and epidemiological data estimation
methods used, and the relative weighting of disabilities.
Development of disease classification
In order to evaluate burden of disease and health care per-
formance, a measure is needed that can be used to quantify
scientific health status and to create a systematically organized
classification system capable of comprehensibly including
every important disease entity.
DALY is a summary measure that represents health status.
Using DALYs, WHO arranged ICD codes into 3 major gro-
ups, 16 sub-categories, and 93 third-level categories. How-
ever, decisions concerning the diseases that should be mea-
sured and the units of estimation used are as important as
the need for a measurement index. In the present study, we
developed a new disease classification that can be used to fully
adjust the structure of diseases in Korea and health care per-
formance.
First, we collected and addressed the disease classifications
used by WHO and other DALYs yielding procedures. Sec-
ond, the characteristics of the data sources used to estimate
DALYs were scrutinized. Third, the project units of public
health activity and public health-related medical services that
are in need of the evaluation of public health performances
were comprehensibly grasped. Fourth, representative data
concerning the disease structure in Korea such as major causes
of death and frequent medical service utilizing diseases were
investigated. Fifth, based on the above, we developed a new
disease classification, which included several added disease
entities, and then consulted a team of clinical and public health
specialists about the new disease classification system.
Our disease classification is based on the Global Burden
of Disease as defined by WHO, and adheres to the principle
that a disease classification should be exhaustive and exclusive.
On the other hand, considering the ease of approach offered
by intervention, and attempt was made to avoid overly detailed
disease classifications. In addition, we added diseases included
in the Korean national infectious disease surveillance system
and the national cancer registration project.
The following diseases (all of which are currently included
in the national communicable disease surveillance system)
were added to group I of the GBD classification (communi-
cable diseases); herpes genitalia, cholera, typhoid and paraty-
phoid, shigellosis, mumps, rubella, and chicken pox. In addi-
tion, we also added pneumonia and influenza to the classifi-
cation system. These were added because they were described
as ‘lower respiratory infections’ in the previous GBD classi-
fication. Moreover, these diseases are included in the Korean
Contagious Disease Prevention Act and thus need to be moni-
tored separately. In group 2 (non-communicable diseases),
gallbladder cancer, thyroid cancer, kidney cancer, brain can-
cer, and bone and cartilage cancer were added to the ‘Malig-
nant neoplasm’ subcategory. These disease entities have been
under continuous surveillance by the Korean National Can-
cer Registry project, and are also included in the list of the
236 most frequent causes of death in Korea. Benign brain
neoplasm was added to the ‘other neoplasms’ subcategory,
because the disease process and final results associated with
brain neoplasms are similar to those of other malignancies.
However, neuro-psychiatric diseases were addressed in a some-
what different manner. Instead of simply adding locally impor-
tant diseases to the current GBD classification, we elected
to change the disease classification hierarchy itself. 
Consequently, we added a new disease group, which includes
19 disease entities, namely, 8 communicable diseases, 6 neo-
plastic diseases, and 5 neuro-psychiatric conditions.
Estimation of epidemiologic parameters
In order to determine the incidences and prevalence of all
disease categories, we constructed a large normative cohort,
representing the Korean population in 1998 as a cooperative
project with the National Health Insurance Corporation of
Korea. The Korean National Health Insurance system is an
obligatory program that covers all 47 million Koreans. Kore-
an National Health Insurance and related data sources have
been previously described in detail (11). We randomly sam-
pled 1,209,693 persons, and stratified them for age into 5-yr
age groups, sex, area of residence (Seoul/large city/other), and
type of insurance (employee/self-governor/medical aid). The
Korean Normative Cohort includes 2.5% of all Koreans, with
and overrepresentation of elderly, to add stability to estimated
parameters (Table 1). For the cohort, morbidity and mortal-
ity outcomes were followed using data links to the National
Health Insurance (KNHI) medical claim and Korean Nation-
al Statistical Office (NSO) databases during the period 1998
until June 2002. ICD-10 codes which are used by both the
KNHI and NSO were reclassified according to disease clas-
sification. All prevalence, incidence, and mortality data were
estimated from unit disease classification. Prevalences (per
1,000 persons per year) were calculated after averaging the
total number (person-base) of those who had been diagnosed
during the follow-up period (1998-2002). Incidences were
calculated for 2000 and 2001 after excluding patients who
had visited hospital during the first two years (i.e., 1998-1999).
To reduce possible over-estimations of morbidity rates caused
by using medical claim data, an operational definition for
each disease category was made by specialists. For example,
cancer cases were counted only when the diagnosis was made
in a general hospital, and there were two or more claims for
the same disease category. Moreover, all bona vide cancer cases
deemed to have required more than one admission event. In
terms of mortality, causes of death as reported by the NSO
were used as was.
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disease groups (asthma, epilepsy, stroke, myocardial infarc-
tion, herniated intervertebral disk, rheumatoid arthritis, sys-
temic lupus erythematosus, lung cancer, and common sur-
gical conditions) were sampled to validate the KNHI diag-
nosis based on a medical record review. The concordance rate,
which was defined based on ‘‘probable cases’’ and ‘‘confirmed
cases’’, was as low as 52.6% for asthma (298 acceptable cases
out of 567 claims) and as high as 84.1% for a herniated inter-
vertebral disk (132 acceptable cases out of 157 claims). Several
factors were found to be associated with validity, i.e., admis-
sion/outpatient, patient age, type of hospital, whether oper-
ations were performed or not, total cost, and length of admis-
sion. Models were constructed to predict the probability of
validity of each case, using the above medical utilization fac-
tors. Original prevalence and incidences were recalculated
by summing predicted probabilities to yield adjusted mor-
bidity rates. Adjusted morbidity rates were compared to those
in previous independent Korean reports when possible.
In order to determine disability duration and average age
at onset, we used the DisMod II model (12). Prevalence,
incidences, and specific mortality rates were required to esti-
mate disability duration and average age at onset.
Disability weight 
When developing our new classification system, it was
found necessary to standardize and quantify a number of social
preferences, in order to accurately deduce a set of disability
weightings. Multiple measurement methods were used to
perform this task, these included person trade off (PTO), time
trade off, visual analogue scale, and standard gamble. In the
GBD study, however, a protocol was developed based on the
PTO measurement scheme (6). In the present study, we select-
ed 16 indicator conditions that fit the Korean context, using
three selection criteria as follows: health state should be mean-
ingful in terms of public health, health status is most popu-
lar, and health status can be represented on a scale from 0
(representing a good state) to 1 (representing a fatal state of
health). After conducting a pilot test of the method using a
group of medical students, the PTO protocol was revised in
order to render it more appropriate for this study. The 16 in-
dicator conditions are as follows: Chronic back pain, Colon
and rectum cancers, Down syndrome, Diabetes mellitus, Pep-
tic ulcer disease, Stomach cancer, Hepatitis B and hepatitis
C, Influenza, pneumonia, Unipolar major depression, Demen-
tia, Low birth weight, Schizophrenia, Iron-deficiency anemia,
Ischemic heart disease, Epilepsy, and Rheumatoid arthritis. 
We then assigned preference weights to selected indicator
conditions using the following procedure. First, 30 doctors
were grouped into three panels of 10 individuals. The pro-
portions of physicians and preventive medicine specialists
were almost same in each panel.
Cohort
Male Female Total
Age group
Sampling rate
Male Female Total
Korean population (2000)
Male Female Total
0-4 42,345 38,256 80,601 1,689,517 1,538,491 3,228,008 2.51 2.49 2.50
5-9 47,821 41,887 89,708 1,903,325 1,676,991 3,580,316 2.51 2.50 2.51
10-14 41,357 37,222 78,579 1,659,786 1,490,692 3,150,478 2.49 2.50 2.49
15-19 48,191 45,161 93,352 1,926,753 1,805,403 3,732,156 2.50 2.50 2.50
20-24 50,586 48,420 99,006 2,021,488 1,922,269 3,943,757 2.50 2.52 2.51
25-29 56,885 53,941 110,826 2,260,009 2,162,330 4,422,339 2.52 2.49 2.51
30-34 57,771 55,392 113,163 2,303,166 2,206,046 4,509,212 2.51 2.51 2.51
35-39 56,073 53,333 109,406 2,242,344 2,123,583 4,365,927 2.50 2.51 2.51
40-44 53,023 50,945 103,968 2,125,313 2,035,562 4,160,875 2.49 2.50 2.50
45-49 38,530 37,251 75,781 1,532,344 1,492,612 3,024,956 2.51 2.50 2.51
50-54 30,177 29,545 59,722 1,195,544 1,178,793 2,374,337 2.52 2.51 2.52
55-59 25,022 26,420 51,442 1,003,925 1,068,758 2,072,683 2.49 2.47 2.48
60-64 20,905 24,518 45,423 840,681 971,217 1,811,898 2.49 2.52 2.51
65-69 14,190 19,621 33,811 568,990 777,065 1,346,055 2.49 2.53 2.51
70-74 8,521 14,106 22,627 336,557 568,539 905,096 2.53 2.48 2.50
75-79 5,189 9,569 14,758 209,170 387,997 597,167 2.48 2.47 2.47
80-84 3,040 6,542 9,582 98,983 218,104 317,087 3.07 3.00 3.02
85-89 1,640 5,138 6,778 34,080 104,093 138,173 4.81 4.94 4.91
90-94 879 3,322 4,201 8,957 33,216 42,173 9.81 10.00 9.96
95-99 501 2,729 3,230 984 6,658 7,642 50.91 40.99 42.27
100+ 370 3,359 3,729 172 2,048 2,220 215.12* 164.01* 167.97*
Total 603,016 606,677 1,209,693 23,962,088 23,770,467 47,732,558 2.52 2.55 2.53
Table 1. Characteristics of the representative Korean Normative Cohort
*This age group included  those who died between 1998 and 2001, which resulted in oversampling compared with the surviving cross-sectional popu-
lation.
In an effort to generate a stable epidemiological indicator, weights of 3% or more were given to age groups of 80 or older as follows: 3% (80-84), 5%
(85-89), 10% (90-94), 50% (95-99), 100% (100 or older).Burden of Disease in Korea 521
The first measurement group contained one female doctor
and the 2nd and 3rd groups two apiece. Second, each of the
three panels was then assigned preference weighting for the
16 indicator conditions, each group taking a different date.
Third, panel members took approximately 30 min to assign
preference weightings to each of the health states, using a
form developed for this study and by following a coordina-
tor’s instructions, were based on PTO1 and PTO2 protocols,
respectively. Panel members recorded values to the questions
asked in these variants, provided reasons for their answers,
and discussed results with other members. After this process
had been repeated three times, each of the members provided
final values for PTO 1 and PTO2 variants. Forth, disability
weightings (DW) were calculated for each of the health states
using the PTO values obtained from the panels, as follows:
DW=1-1000/PTO1=1000/PTO2. Fifth, median disability
weights were recorded on the disability scale, for each of the
16 indicator conditions.
Then, for health states other than those covered by the 16
indicator conditions, each panel member was presented with
a set of 37 health states; 30 of which were selected from dif-
ferent categories and 7 from a list of common core diseases.
Panel members then assigned preference weights to a total
of 123 health states, including the indicator conditions, by
interpolation, using the disability scale that had been devel-
oped for the indicator conditions.
Finally, the study employed generalizability theory, which
is commonly used in the reliability behavior theory, to esti-
mate the relative magnitudes of various components of mea-
surements (generalizability study or G study), by analyzing
the reliability coefficient (G coefficient) and ensuring the
desired level of reliability (decision study or D study) (13, 14).
The results of this G study revealed that the degree of con-
tribution made by the 16 indicator conditions was 78.3%.
This indicates that the total variance could be explained by
the indicator conditions, and that the measurement errors
associated with panels and panel members were essentially
insignificant. In terms of total variance, 5.2% was explained
by all of the other interactions among the sources of error. The
D study showed that the generalizability coefficient was greater
than 0.9 in all nine, which suggests a high level of reliabili-
ty. The generalizability coefficient associated with research
design (i.e., indicator conditions, taking triplicorte measure-
ments, 10 respondents for each panel) was also found to be
high, at 0.973.
After completing this process, we estimated DALYs with
regard to disease burden in the Korean population.
RESULTS
The burdens imposed by major disease groups (DALYs
lost per 100,000 of the population) are shown in Fig. 1. Can-
cer was found to be the most prominent cause of disease bur-
den, with a score of 1,525, followed by cardiovascular diseases
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Fig. 1. Burden of disease (years of life lost to premature mortality
[YLL], years of life lost due to disability [YLD] and total disability-
adjusted life years [DALYs]) for broad disease groups in Korea
in 2002.
Note: DALYs due to injuries are excluded.
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Fig. 2. Top twenty diseases as determined by burden of disease
(years of life lost to premature mortality [YLL], years of life lost due
to disability [YLD] and total disability-adjusted life years [DALYs])
for major diseases in Korean men in 2002.
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(1,492), digestive diseases (1,140), diabetes mellitus (970),
respiratory diseases (951), and neuro-psychiatric conditions
(883). The mortality burden of cancer (YLLs lost per 100,000
of the population) was determined to be the leading cause
of premature mortality, with a score of 1,222, and this was
followed by cardiovascular diseases (768), digestive diseases
(368) and diabetes mellitus (291). Digestive diseases were
determined to be the leading causes of disability in Korea
(injuries not included), with a YLD of 853 per 100,000 indi-
viduals, followed by respiratory diseases (841), neuro-psychi-
atric conditions (768), and cardiovascular diseases (735) (Fig.
1). A list of the top twenty leading causes of disease burden
among men (DALYs lost per 100,000 of the population) is
shown in Fig. 2. Diabetes mellitus was found to be associat-
ed with the highest burden of disease with 1,020 DALYs,
followed by CVA (937), cirrhosis of the liver (671), asthma
(663), and ischemic heart disease (601). By individual dis-
ease, in men, diabetes mellitus exhibited the highest YLD,
at 801 per 100,000 individuals, followed by asthma (610)
and peptic ulcer disease (547) (Fig. 2).
The top twenty leading causes of disease burden among
women (DALYs lost per 100,000 of the population) are shown
in Fig. 3. Diabetes mellitus was associated with the highest
DALY rate, with a score of 919, followed by cardiovascular
disease (900), peptic ulcer disease (794), and asthma (755)
(Fig. 3). In women, peptic ulcer disease had the highest YLD,
at 788, followed by diabetes mellitus (740) and asthma (710)
(Fig. 3).
The burden attributable to unipolar major depression was
determined to be twice as high in women than in men, where-
as the disability burden associated with cirrhosis of the liver
was determined to be 3.7 times as high in men than in women
(Fig. 2, 3).
DISCUSSION
In this study, the authors attempted to measure the burden
of disease in Korea, using DALYs. This study represents one
of the first examples of such calculations using epidemiologic
data and disability weights derived in an Asian country.
DALY, as applied in this study, is a single measurement that
consists of a summation of time lost as a result of premature
death and time lived under disabling conditions. The primary
reason why this indicator has attracted the attentions of resear-
chers in the public health area is that it can be used as a tool
for simultaneously measuring the level of death and prevalence
(8, 15).
The developed classification described above has been found
to be a useful tool for many health related studies in Korea
and allows comparative studies to be conducted between coun-
tries. WHO recommends that a summary measure should
correctly reflect the characteristics of a country or region, and
that to achieve an intensive study concentrated on a target-
ed nation should take priority over any other procedures.
The results are expected to provide us with supportive data
for evidence-based decision-making and health resource allo-
cation. The results obtained reveal that the burden of disease
in Korea originates primarily from cancers, cardiovascular
disease, digestive disease, diabetes mellitus, and neuro-psy-
chiatric conditions (Fig. 1). Our findings in this regard are
comparable with, but clearly different from, a similar study
conducted in Australia (3). In Australia, the burden of dis-
ease ranking in men per 100,000 persons using DALY (not
including injuries) was found to be cardiovascular disease,
cancer, mental disorders, nervous system diseases, and chron-
ic respiratory diseases (3). 
Our findings also clearly differ from those of the GBD study
for the EME (3, 6), in which the top ranked diseases using
DALYs (not including injuries) were ischemic heart disease,
cerebrovascular disease, dementia, tracheal, bronchial and
lung cancer, unipolar major depression, and osteoarthritis (3,
6), whereas in Korea, the top leading causes were diabetes
mellitus, cerebrovascular disease, asthma, peptic ulcer disease,
ischemic heart disease, and cirrhosis of the liver.
These results indicate that the burden of digestive diseases,
such as, peptic ulcer disease and cirrhosis of the liver, are higher
in Korea than in Australia. Korea’s higher level of digestive
disease burden, especially its higher mortality is explained
by a high prevalence of hepatitis B infection and the dietary
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Fig. 3. Top twenty diseases as determined by burden of disease
(years of life lost to premature mortality [YLL], years of life lost due
to disability [YLD] and total disability-adjusted life years [DALYs])
for primary diseases in Korean women in 2002.
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habits of Koreans, who traditionally consume great quanti-
ties of salty, highly spiced food (16, 17).
The present study has several limitations. First, some degree
of uncertainty was introduced by estimating epidemiologic
parameters using medical utilization data. Especially, this
study did not have exact information regarding utilization
data of oriental medicine, pharmacy. However, we found that
our results are in line with previous studies on estimated dis-
ease incidence in Korea (8, 18). Nevertheless, no prevalences
or incidences were available for most disease categories, and
thus, there remains a possibility that morbidity rates could
have been over- or under- estimated (8). Especially, the pos-
sibility remains that morbidity rates of older age group could
have been overestimated due to the over-sampling method
in this study (Table 1). Moreover, the cohort approach used
in the present study provided direct estimates and represen-
tative morbidity rates for all disease categories, with a certain
degree of reliability. Second, computerized data regarding
cause of death is not entirely accurate. This is because death
certificates are not always issued by physicians, and even when
a diagnosis is rendered by a physician, discrepancies some-
times exist between recorded causes of death and actual causes
(19). Third, it has also been found to be impossible to deter-
mine the burden of disease attributable to injuries in Korea
because resulting insurance claims do not contain details of
injury type. Moreover, given that the attributable burden of
injuries is substantial, this failure to incorporate the influence
of injuries into DALY calculations constitutes a major limi-
tation of this study. Finally, the Korean Burden of Disease
study is limited by its lack of adjustment for comorbidities,
which are likely to affect diseases like diabetes and ischemic
heart disease and thus increase the burden of disease (5).
In conclusion, despite the limitations of the data utilized
in this study, we are confident that DALY is an appropriate
and reasonably accurate tool in the public health area, as has
been found in the Netherlands and Australia. Moreover, the
present study also provided the basic epidemiologic data to
establish an evidence-based health policy.
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